654
Views
10
CrossRef citations to date
0
Altmetric
Review

Rho GTPase effectors and NAD metabolism in cancer immune suppression

, , , , , & show all
Pages 9-17 | Received 11 Oct 2017, Accepted 30 Nov 2017, Published online: 10 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yan Lv, Kai Gai, Xia Ding & Weihua Sun. (2023) Soluble forms of PD-1 and sPD-L1/2 in serum and urine of patients with head and neck cancer and their clinical significance. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-12.
Read now
Hanxun Wang, Peilu Song, Yinli Gao, Lanlan Shen, Hanqin Xu, Jian Wang & Maosheng Cheng. (2021) Drug discovery targeting p21-activated kinase 4 (PAK4): a patent review. Expert Opinion on Therapeutic Patents 31:11, pages 977-987.
Read now

Articles from other publishers (8)

Jianye Zhong, Abai Xu, Peng Xu, Minhong Su, Peng Wang, Zhe Liu, Boping Li, Chunxiao Liu & Ning Jiang. (2023) Circ_0000235 targets MCT4 to promote glycolysis and progression of bladder cancer by sponging miR-330-5p. Cell Death Discovery 9:1.
Crossref
Masaki Shiota, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Tokiyoshi Tanegashima, Shoji Tokunaga & Masatoshi Eto. (2023) Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial. Cancer Immunology, Immunotherapy 72:6, pages 1903-1915.
Crossref
Eva Crosas-Molist, Remi Samain, Leonie Kohlhammer, Jose L. Orgaz, Samantha L. George, Oscar Maiques, Jaume Barcelo & Victoria Sanz-Moreno. (2022) Rho GTPase signaling in cancer progression and dissemination. Physiological Reviews 102:1, pages 455-510.
Crossref
Elisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, Tomás Alarcón, Ruth Lupu, Joaquim Bosch-Barrera & Javier A. Menendez. (2020) Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy. Cancers 12:7, pages 1757.
Crossref
Cunhua Zou, Yali Lyu, Jing Jiang, Yuan Cao, Min Wang, Changmei Sang, Ruirui  Zhang, Haifeng Li, Choong‑Chin Liew, Changming Cheng & Shuping Zhao. (2020) Use of peripheral blood transcriptomic biomarkers to distinguish high‑grade cervical squamous intraepithelial lesions from low‑grade lesions. Oncology Letters 20:3, pages 2280-2290.
Crossref
Hongyi Zhang, Longchao Liu, Jian Zhang, Jiahui Chen, Jianfeng Ye, Sachet Shukla, Jian Qiao, Xiaowei Zhan, Hao Chen, Catherine J. Wu, Yang-Xin Fu & Bo Li. (2020) Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers. Clinical Cancer Research 26:6, pages 1359-1371.
Crossref
Christine M. Heske. (2020) Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy. Frontiers in Oncology 9.
Crossref
Ruth Nussinov, Hyunbum Jang, Chung-Jung Tsai & Feixiong Cheng. (2019) Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers. PLOS Computational Biology 15:3, pages e1006658.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.